Additional Coverage:
- FDA issues update on popular breakfast staple recalled in 40 states: Key details revealed (marketrealist.com)
FDA Elevates Warning on Recalled Peanut Butter Products Across 40 States
[City, State] – The U.S. Food and Drug Administration (FDA) has upgraded its warning level for a previously recalled peanut butter product, now classifying it as a Class-II risk. This designation indicates that consumption of the affected products could lead to temporary or medically reversible adverse health consequences.
The voluntary recall was initiated by Ventura Foods after the discovery of blue plastic pieces in a production filter. While no injuries or illnesses have been reported to date, consumers are advised to exercise caution.
The recall primarily impacts 0.5-ounce and 0.75-ounce peanut butter-only packets, as well as 1.12-ounce packs, sold under various distributor and private-label brands. These include US Foods, DYMA Brands, FLAVOR Fresh, Sysco House Recipe, Katy’s Kitchen, and Gordon Food Service. The total quantities involved are substantial, with 17,115 cases of 0.75-ounce packs, 4,496 cases of 0.5-ounce packs, and 516 cases of 1.12-ounce packs.
Beyond standalone peanut butter, the recall also extends to products where peanut butter is an ingredient. Notably, this includes Poco Pac twin-packs that combine creamy peanut butter with strawberry jam or grape jelly in 1.12-ounce and 1-ounce cups.
The affected products were widely distributed across 40 states, encompassing: Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, and Wisconsin.
Ventura Foods LLC emphasized their proactive response to the situation. A spokesperson stated, “While the U.S.
Food and Drug Administration investigation and classification process is thorough and can take time to complete, that timeline did not impact our actions. At the time the recall was initiated, on April 30, 2025, we acted with urgency to remove all potentially impacted product from the marketplace.
This includes urging our customers, their distributors, and retailers to immediately review their inventory, segregate, and stop the further sale and distribution of any products subject to the recall.”
The company reiterated its commitment to consumer safety, adding, “Protecting consumers remains our top priority, and we will continue to act swiftly and transparently as the FDA review progresses.”
Consumers are strongly encouraged to check the lot codes of their peanut butter products against the information provided by the FDA and to immediately remove any matching items from use. The FDA has not yet provided a timeline for the termination of this notice.